Uncover key drivers, emerging technologies, and competitive movements shaping the photodynamic therapy market from 2025–2034 with trusted insights from The Business Research Company
How Will The Photodynamic Therapy Market Size Evolve Between Now And 2029?
The antifungals market has shown significant growth in recent years. This market is projected to expand from $27.16 billion in 2024 to $29.6 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.0%. Historically, this expansion has been driven by factors such as the prevalence of fungal diseases, an aging global population, developments in healthcare infrastructure, and increased awareness and education.
The antifungals market is anticipated to show significant expansion over the next few years. It is forecast to expand to “$41.2 billion by 2029, achieving a compound annual growth rate (CAGR) of 8.6%. The expansion during the projected period stems from factors such as evolving fungal strains, governmental regulatory approvals, widespread global health issues, increased spending on healthcare, and enhanced patient education and awareness. Prominent developments expected in this forecast period involve dedicated research and development, the rise of telemedicine and e-health services, continuous advancements in antifungal drug creation, and various collaborations and partnerships.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2442&type=smp
Which Key Drivers Are Powering Growth In The Photodynamic Therapy Market?
The rising occurrence of fungal infections is anticipated to boost the expansion of the antifungals market in the future. These are illnesses resulting from fungi invading and growing within or on the body, capable of impacting diverse areas such as the skin, nails, lungs, and mucous membranes. This rise in prevalence stems from several contributing factors, including an increase in immunocompromised individuals, climate change fostering conditions conducive to fungal growth, the greater use of broad-spectrum antibiotics disrupting natural microbiomes, inadequate hygiene, urbanization, and the expanding incidence of chronic diseases like diabetes which heighten susceptibility to these infections. Antifungal agents are vital in managing fungal diseases. They work by hindering the growth and replication of fungi, either through disturbing their cell walls or membranes, obstructing key enzymatic processes, or impeding their synthesis of crucial components. This action ultimately decreases the fungal burden, eases symptoms, and halts the infection’s spread throughout the body. For example, data from September 2024, provided by the International Society For Infectious Diseases, a US-based non-profit organization, indicated an annual occurrence of 6.5 million invasive fungal infections. These were linked to approximately 3.8 million mortalities, with 2.5 million (68%; range 35-90%) of these deaths directly caused by such infections. Consequently, the escalating incidence of fungal infections is projected to propel the antifungals market.
How Is The Global Photodynamic Therapy Market Structured By Key Segments?
The antifungals market covered in this report is segmented –
1) By Drug Type: Echinocandins, Azoles, Polyenes, Allylamines
2) By Route of Administration: Oral, Parenteral, Topical
3) By End users: Hospitals & Clinics, Dermatology clinics, Other Users
Subsegments:
1) By Echinocandins: Caspofungin, Micafungin, Anidulafungin
2) By Azoles: Fluconazole, Itraconazole, Voriconazole, Posaconazole, Ketoconazole
3) By Polyenes: Amphotericin B, Nystatin
4) By Allylamines: Terbinafine, Naftifine
What Future-Focused Trends Are Anticipated In The Photodynamic Therapy Market?
Pharmaceutical developers and manufacturers are enhancing their various departments, including research and development, marketing, and manufacturing, by forming collaborations and strategic partnerships with other organizations and research institutions, with the goal of expanding their product portfolios. Consequently, businesses within the anti-infective drugs market should evaluate strategic collaborations to broaden their operational scope and product offerings, which will help them increase revenue and remain competitive in the market.
Which Companies Hold A Competitive Edge In The Photodynamic Therapy Market?
Major companies operating in the antifungals market include Pfizer Inc., Novartis International AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Sanofi S.A., Kramer Laboratories Inc., GlaxoSmithKline plc, Gilead Sciences Inc., Basilea Pharmaceutica AG, Sigma-Aldrich, Astellas Pharma Inc., Janssen Pharmaceutica NV, Zydus Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co. Ltd., Scynexis Inc., Mayne Pharma Inc., Cosmo Pharmaceuticals NV, Leadiant Biosciences Inc, Glenmark Pharmaceuticals Limited, Cidara Therapeutics, MATINAS BIOPHARMA, Mylan N.V., Perrigo Company plc, Wockhardt Ltd., Lupin Limited, Dr. Reddy’s Laboratories Ltd, Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Mayne Pharma Group Limited, Fresenius Kabi AG, Baxter International Inc., Akorn Operating Company LLC, Amphastar Pharmaceuticals Inc., Mylan Institutional LLC, West-Ward Pharmaceuticals Corp., Gland Pharma Limited, Aurobindo Pharma Limited
Download The Full Report Here:
https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report
Which Region Is Expected To Lead The Photodynamic Therapy Market In The Next Few Years?
North America was the largest region in the drugs for antifungals market in 2024. The Middle East is expected to be the fastest-growing region in the antifungals market. The regions covered in the antifungals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=2442&type=smp
Browse Through More Reports Similar to the Global Photodynamic Therapy Market 2025, By The Business Research Company
Gastrointestinal Drug Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report
Smart Pills Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/smart-pills-global-market-report
Organ On Chip Market 2025
https://www.thebusinessresearchcompany.com/report/organ-on-chip-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
